Cureus | A Patient of Multiple Myeloma with Absent M-spike on Serum Protein Electrophoresis and Elevated Serum-Free Light Chains: A Case Report and Literature Review
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
Living With
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis - Mayo Clinic Proceedings
Frontiers | Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
FREE LIGHT CHAINS (SERUM) | REGIONAL MEDICAL LABORATORY
Correspondence data for kappa and lambda free light chain analysis | Download Table
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
FREE LIGHT CHAINS (SERUM) | REGIONAL MEDICAL LABORATORY
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Examples of abnormal kappa/lambda free light chain (κ/λ FLC) ratios in... | Download Table
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Free Light Chains (Kappa & Lambda) test: Procedure, Purpose, Results, Normal values, Cost, Price, Online booking
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
